ALC logo

ALC
Alcon Inc. - Registered Shares

559
Mkt Cap
$38.02B
Volume
1.46M
52W High
$99.20
52W Low
$71.55
PE Ratio
39.26
ALC Fundamentals
Price
$78.01
Prev Close
$77.40
Open
$79.11
50D MA
$79.09
Beta
0.76
Avg. Volume
1.49M
EPS (Annual)
$1.99
P/B
1.73
Rev/Employee
$400,932.85
$43,337.51
Loading...
Loading...
News
all
press releases
Top Research Reports for Bank of America, GE Aerospace & T-Mobile
BAC, GE, and TMUS anchor fresh research as analysts flag growth drivers, rising costs, and competitive pressures shaping outlooks across banking, aerospace, and telecom.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
GMED rides on NuVasive synergies, strong cash flow and rapid innovation, but macro pressures and rising costs cloud its near-term outlook.
Zacks·2d ago
News Placeholder
Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS
ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.
Zacks·4d ago
News Placeholder
Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
This season, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Systane has partnered with the Toronto Blue Jays as the official eye drop of the team...
Business Wire·5d ago
News Placeholder
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of Clareon TruPlus, its new enhanced design monofocal and toric...
Business Wire·6d ago
News Placeholder
Alcon Publishes Agenda for 2026 Annual General Meeting
Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 30, 2026. Alcon is pleased to welcome shareholders to its fourth in-person AGM since becoming...
Business Wire·10d ago
News Placeholder
LENSAR Q4 Earnings Call Highlights
LENSAR (NASDAQ:LNSR) executives used the company's fourth-quarter and full-year 2025 earnings call to outline how the cataract-laser maker plans to reaccelerate growth as a standalone company...
MarketBeat·12d ago
News Placeholder
LENSAR Stock Plunges Alcon Scraps Merger After Prolonged Regulatory Review
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.read more...
Benzinga·26d ago
News Placeholder
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback
Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23.
Stocktwits·27d ago
News Placeholder
Alcon Ends Merger Agreement With LENSAR After FTC Opposition
(RTTNews) - Alcon Inc. (ALC) announced on Monday that it has agreed with LENSAR, Inc. (LNSR) to terminate their previously announced merger agreement...
Nasdaq News: Markets·27d ago
<
1
2
...
>

Latest ALC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.